Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02569346Phase 1Completed
Phase 1, randomised, open-label trial of abacavir in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Area Under the Curve up to 48 hours. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02569346.